93 related articles for article (PubMed ID: 11665561)
1. Strategies for mapping the binding site of the serotonin 5-HT2A receptor.
Ebersole BJ; Sealfon SC
Methods Enzymol; 2002; 343():123-36. PubMed ID: 11665561
[No Abstract] [Full Text] [Related]
2. Molecular basis of partial agonism: orientation of indoleamine ligands in the binding pocket of the human serotonin 5-HT2A receptor determines relative efficacy.
Ebersole BJ; Visiers I; Weinstein H; Sealfon SC
Mol Pharmacol; 2003 Jan; 63(1):36-43. PubMed ID: 12488534
[TBL] [Abstract][Full Text] [Related]
3. Theoretical models of interactions between buspirone analogues and 5-HT1A and 5-HT2A serotonin receptor subtypes.
Bronowska A; Sylte I; Edvardsen Ø; Østensen R; Leś A; Chilmonczyk Z
Acta Pol Pharm; 2000 Nov; 57 Suppl():40-5. PubMed ID: 11293260
[TBL] [Abstract][Full Text] [Related]
4. Differential modes of agonist binding to 5-hydroxytryptamine(2A) serotonin receptors revealed by mutation and molecular modeling of conserved residues in transmembrane region 5.
Shapiro DA; Kristiansen K; Kroeze WK; Roth BL
Mol Pharmacol; 2000 Nov; 58(5):877-86. PubMed ID: 11040033
[TBL] [Abstract][Full Text] [Related]
5. Different regulation of rat 5-HT(2A) and rat 5-HT(2C) receptors in NIH 3T3 cells upon exposure to 5-HT and pipamperone.
Oekelen DV; Jurzak M; Van de Wiel D; Van Hecke G; Luyten WH; Leysen JE
Eur J Pharmacol; 2001 Aug; 425(1):21-32. PubMed ID: 11672571
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, receptor potency, and selectivity of halogenated diphenylpiperidines as serotonin 5-HT2A ligands for PET or SPECT brain imaging.
Fu X; Tan PZ; Kula NS; Baldessarini R; Tamagnan G; Innis RB; Baldwin RM
J Med Chem; 2002 May; 45(11):2319-24. PubMed ID: 12014970
[TBL] [Abstract][Full Text] [Related]
7. Identification of the binding sites and selectivity of sarpogrelate, a novel 5-HT2 antagonist, to human 5-HT2A, 5-HT2B and 5-HT2C receptor subtypes by molecular modeling.
Rashid M; Manivet P; Nishio H; Pratuangdejkul J; Rajab M; Ishiguro M; Launay JM; Nagatomo T
Life Sci; 2003 May; 73(2):193-207. PubMed ID: 12738034
[TBL] [Abstract][Full Text] [Related]
8. 9-(Aminomethyl)-9,10-dihydroanthracene is a novel and unlikely 5-HT2A receptor antagonist.
Westkaemper RB; Runyon SP; Bondarev ML; Savage JE; Roth BL; Glennon RA
Eur J Pharmacol; 1999 Sep; 380(1):R5-7. PubMed ID: 10513561
[TBL] [Abstract][Full Text] [Related]
9. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
Almaula N; Ebersole BJ; Ballesteros JA; Weinstein H; Sealfon SC
Mol Pharmacol; 1996 Jul; 50(1):34-42. PubMed ID: 8700116
[TBL] [Abstract][Full Text] [Related]
10. Site-directed mutagenesis of the 5-HT1B receptor increases the affinity of 5-HT for the agonist low-affinity conformation and reduces the intrinsic activity of 5-HT.
Grånäs C; Nordquist J; Mohell N; Larhammar D
Eur J Pharmacol; 2001 Jun; 421(2):69-76. PubMed ID: 11399261
[TBL] [Abstract][Full Text] [Related]
11. Primary structure of the human platelet serotonin 5-HT2A receptor: identify with frontal cortex serotonin 5-HT2A receptor.
Cook EH; Fletcher KE; Wainwright M; Marks N; Yan SY; Leventhal BL
J Neurochem; 1994 Aug; 63(2):465-9. PubMed ID: 8035173
[TBL] [Abstract][Full Text] [Related]
12. Creation of a constitutively activated state of the 5-HT2A receptor by site-directed mutagenesis: revelation of inverse agonist activity of antagonists.
Egan C; Herrick-Davis K; Teitler M
Ann N Y Acad Sci; 1998 Dec; 861():136-9. PubMed ID: 9928250
[TBL] [Abstract][Full Text] [Related]
13. The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors.
Bonhaus DW; Bach C; DeSouza A; Salazar FH; Matsuoka BD; Zuppan P; Chan HW; Eglen RM
Br J Pharmacol; 1995 Jun; 115(4):622-8. PubMed ID: 7582481
[TBL] [Abstract][Full Text] [Related]
14. Identification of an amino acid residue important for binding of methiothepin and sumatriptan to the human 5-HT(1B) receptor.
Grånäs C; Larhammar D
Eur J Pharmacol; 1999 Sep; 380(2-3):171-81. PubMed ID: 10513577
[TBL] [Abstract][Full Text] [Related]
15. Induction of a high-affinity ketanserin binding site at the 5-Hydroxytryptamine(1B) receptor by modification of its carboxy-terminal intracellular portion.
Wurch T; Palmier C; Pauwels PJ
Biochem Pharmacol; 2000 May; 59(9):1117-21. PubMed ID: 10704941
[TBL] [Abstract][Full Text] [Related]
16. Spiperone: influence of spiro ring substituents on 5-HT2A serotonin receptor binding.
Metwally KA; Dukat M; Egan CT; Smith C; DuPre A; Gauthier CB; Herrick-Davis K; Teitler M; Glennon RA
J Med Chem; 1998 Dec; 41(25):5084-93. PubMed ID: 9836624
[TBL] [Abstract][Full Text] [Related]
17. A novel (benzodifuranyl)aminoalkane with extremely potent activity at the 5-HT2A receptor.
Parker MA; Marona-Lewicka D; Lucaites VL; Nelson DL; Nichols DE
J Med Chem; 1998 Dec; 41(26):5148-9. PubMed ID: 9857084
[No Abstract] [Full Text] [Related]
18. The 5-HT7 receptor: orphan found.
Eglen RM; Jasper JR; Chang DJ; Martin GR
Trends Pharmacol Sci; 1997 Apr; 18(4):104-7. PubMed ID: 9149537
[No Abstract] [Full Text] [Related]
19. Identification of two serine residues essential for agonist-induced 5-HT2A receptor desensitization.
Gray JA; Compton-Toth BA; Roth BL
Biochemistry; 2003 Sep; 42(36):10853-62. PubMed ID: 12962510
[TBL] [Abstract][Full Text] [Related]
20. [Effect of hypothyroidism on 5-HT1A-, 5-HT2A-receptors and serotonin transporter in the rat brain].
Kulikov AV; Jeanningro R
Ross Fiziol Zh Im I M Sechenova; 2000 Mar; 86(3):312-9. PubMed ID: 10808528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
